Bio-path holdings inc (BPTH)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Revenue

-

-

37

13

0

0

0

0

0

0

Operating expenses
Research and development

4,585

4,603

5,480

5,474

3,020

1,630

1,518

1,132

-

-

General and administrative

4,108

3,379

3,523

3,014

2,465

2,715

1,634

986

1,224

1,126

Impairment of technology license

0

608

0

-

-

-

-

-

-

-

Total operating expenses

8,693

8,590

9,003

8,488

5,485

4,542

3,269

2,582

2,365

2,326

Net operating loss

-8,693

-8,590

-8,966

-8,475

-5,485

-4,542

-3,269

-2,582

-2,365

-2,326

Other income (loss)
Change in fair value of warrant liability

-

-

-2,374

-1,713

0

0

-

-

-

-

Loss on extinguishment of warrant liability

-

-

-440

0

-

-

-

-

-

-

Interest income

94

7

9

12

18

23

4

0

2

1

Other income

-

-

-

-

-

-

-

-

0

244

Other expense

-

-

-

-

-

-

0

0

0

0

Total other income

94

7

1,943

1,725

18

23

3

0

2

244

Net loss before income taxes

-

-

-

-

-

-

-3,266

-2,582

-2,363

-2,081

Income tax expense

-

-

-

-

-

-

0

0

0

0

Net loss

-8,599

-8,583

-7,023

-6,750

-5,467

-4,519

-3,266

-2,582

-2,363

-2,081

Deemed dividend related to warrant conversion

-

-

1,038

0

-

-

-

-

-

-

Net loss attributable to common stockholders

-

-

-8,061

-6,750

-

-

-

-

-

-

Net loss per share, basic and diluted (in dollars)

-3.24

-14.38

-15.99

-0.73

-0.06

-0.05

-0.05

-0.04

-0.04

-0.04

Basic and diluted weighted average number of common shares outstanding

2,657

597

504

9,270

89,763

89,282

71,372

59,317

53,844

-

Basic and diluted weighted average number of common shares outstanding

-

-

-

-

-

-

-

-

-

48,153